| Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1 (NCT06777264) | First Affiliated Hospital of Zhejiang University | 2025-01-15 |
| The ctDNA-RECIST Trial Part One (NCT06562348) | Karen-Lise Garm Spindler | 2025-01-15 |
| Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer (NCT06006013) | Emory University | 2025-01-15 |
| A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01) (NCT06395090) | Merck Sharp & Dohme LLC | 2025-01-15 |
| Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer (NCT06759090) | Zhejiang University | 2025-01-15 |
| Capecitabine in Low Risk Triple Negative Breast Cancer (NCT06787339) | Fudan University | 2025-01-15 |
| Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy (NCT06758037) | First Affiliated Hospital of Ningbo University | 2025-01-15 |
| ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs (NCT06775743) | Fudan University | 2025-01-15 |
| Hypofractionated WPPT With HDR Boost (NCT06591819) | Abramson Cancer Center at Penn Medicine | 2025-01-15 |
| Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung Cancer (NCT06779539) | West China Hospital | 2025-01-15 |
| Dara-BCD for Rare MGRS (NCT06771180) | Peking University People's Hospital | 2025-01-15 |
| Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity (NCT06756061) | Byung-Sik Cho | 2025-01-15 |
| Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia (NCT06793228) | Henan Cancer Hospital | 2025-01-15 |
| To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years (NCT06756269) | Shanghai Bovax Biotechnology Co., Ltd. | 2025-01-15 |
| LDRT and Chemoimmunotherapy in NPC With Liver Metastasis (NCT06788002) | Hunan Cancer Hospital | 2025-01-14 |
| Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia (NCT06731868) | Luye Pharma Group Ltd. | 2025-01-14 |
| A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL (NCT06855823) | Sun Yat-sen University | 2025-01-14 |
| Dopaminergic Disruption Induced by Traumatic Coma: Dopaminergic Pathways Abnormalities and Biomarkers of Recovery Using MRI and 18F-LBT-999 PET (NCT06930261) | Institut National de la Santé Et de la Recherche Médicale, France | 2025-01-14 |
| Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC (NCT06219317) | European Organisation for Research and Treatment of Cancer - EORTC | 2025-01-14 |
| Newborn Jaundice - An Investigation of Different Approaches to Light Therapy (NCT06702241) | Regionshospital Nordjylland | 2025-01-14 |
| Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment (NCT06033703) | Massachusetts Eye and Ear Infirmary | 2025-01-14 |
| A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors (NCT06695845) | Jazz Pharmaceuticals | 2025-01-14 |
| A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy (NCT06456463) | Stemline Therapeutics, Inc. | 2025-01-14 |
| Psilocybin-Assisted Therapy for Physician Well-Being and Burnout (NCT06814522) | University of California, San Diego | 2025-01-13 |
| Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions (NCT06658405) | Centre Oscar Lambret | 2025-01-13 |
| A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients (NCT06771063) | Cisen Pharmaceutical CO., LTD. | 2025-01-13 |
| Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD (NCT06757504) | Shanghai Auzone Biological Technology Co., Ltd. | 2025-01-13 |
| Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery (NCT06780592) | Huashan Hospital | 2025-01-13 |
| Informing Oral Nicotine Pouch Regulations to Promote Public Health (NCT06315881) | Ohio State University Comprehensive Cancer Center | 2025-01-13 |
| A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110 (NCT06677307) | Korro Bio, Inc. | 2025-01-13 |
| GLP-1R Agonist Treatment for Opioid Use Disorder (NCT06548490) | Milton S. Hershey Medical Center | 2025-01-13 |
| Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) (NCT06775041) | PRG Science & Technology Co., Ltd. | 2025-01-13 |
| A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor (NCT06365840) | ImmuneOncia Therapeutics Inc. | 2025-01-13 |
| Nitrous Oxide in the Treatment of Acute Suicidal Ideation (NCT06636357) | University of Zurich | 2025-01-13 |
| Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT) (NCT06321536) | Emory University | 2025-01-13 |
| Comparative Analysis Of Dexmedetomidine And Dexamethasone As An Adjuvant To 0.5%Ropivacaine On Onset Of Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries (NCT07290595) | Sahiwal medical college sahiwal | 2025-01-13 |
| ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults (NCT07392723) | Michal Schnaider Beeri, Ph.D. | 2025-01-12 |
| Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL (NCT07244406) | Hebei Senlang Biotechnology Inc., Ltd. | 2025-01-10 |
| Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL (NCT06760039) | Sun Yat-sen University | 2025-01-10 |
| Psilocybin rTMS for Treatment Resistant Depression (NCT06132178) | University of Texas at Austin | 2025-01-10 |
| An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures (NCT06908356) | Praxis Precision Medicines | 2025-01-10 |
| Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD) (NCT06852768) | Regenerative Ocular Immunobiologics LLC | 2025-01-10 |
| Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression (NCT06559826) | Icahn School of Medicine at Mount Sinai | 2025-01-10 |
| Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC (NCT07748325) | Sichuan University | 2025-01-10 |
| A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD (NCT06659549) | Galimedix Therapeutics Inc | 2025-01-10 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis (NCT06754462) | Immunovant Sciences GmbH | 2025-01-10 |
| Topical Anti-Androgens in Pilonidal Sinus Disease (NCT06286397) | University of Pennsylvania | 2025-01-10 |
| Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy (NCT06373211) | Assistance Publique - Hôpitaux de Paris | 2025-01-10 |
| AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom) (NCT06332807) | NGGT INC. | 2025-01-10 |
| Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer (NCT06734130) | H. Lee Moffitt Cancer Center and Research Institute | 2025-01-10 |
| A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (NCT06706076) | BlossomHill Therapeutics | 2025-01-09 |
| A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer (NCT07005336) | TJ Biopharma Co., Ltd. | 2025-01-09 |
| 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer (NCT06449781) | Maria Sklodowska-Curie National Research Institute of Oncology | 2025-01-09 |
| Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial (NCT06132685) | Emory University | 2025-01-09 |
| A Study of SHR-4375 in Subjects With Solid Tumors (NCT06764628) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-01-09 |
| A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines (NCT06481475) | Chongqing Claruvis Pharmaceutical Co., Ltd. | 2025-01-09 |
| Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy (NCT06128980) | Herlev and Gentofte Hospital | 2025-01-09 |
| A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (NCT06809179) | VistaGen Therapeutics, Inc. | 2025-01-09 |
| Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial (NCT06661902) | University of Washington | 2025-01-09 |
| Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization (NCT06596291) | Cyllene Therapeutics | 2025-01-08 |
| DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma (NCT06504381) | University of California, San Francisco | 2025-01-08 |
| A Phase 2 Study of HX301 in Patients with High-grade Giloma (NCT06703255) | Hangzhou Hanx Biopharmaceuticals, Ltd. | 2025-01-08 |
| Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects (NCT06688123) | Jiangsu HengRui Medicine Co., Ltd. | 2025-01-08 |
| A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab (NCT06782555) | ImmunoGenesis | 2025-01-08 |
| Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma (NCT06801730) | Zhifeng Tian,MD | 2025-01-08 |
| Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis (NCT06718933) | Fudan University | 2025-01-08 |
| Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC (NCT05669846) | Diwakar Davar | 2025-01-08 |
| Effect of Psiguavin for Obesity Treatment (PSIGUAVIN) (NCT06512818) | Universidad Católica San Antonio de Murcia | 2025-01-08 |
| Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer (NCT06522919) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2025-01-07 |
| A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML) (NCT06773208) | Memorial Sloan Kettering Cancer Center | 2025-01-07 |
| Kick-Nic! Youth Quit Vaping App (NCT06662305) | Yale University | 2025-01-07 |
| A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection (NCT06799741) | AbViro LLC | 2025-01-07 |
| A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis (NCT06773195) | Memorial Sloan Kettering Cancer Center | 2025-01-07 |
| A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer (NCT06757335) | Hinova Pharmaceuticals Inc. | 2025-01-07 |
| Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (NCT06768307) | Peking University Cancer Hospital & Institute | 2025-01-07 |
| Clonidine in Ultrasound-guided Rectus Sheath Block for Outpatient Umbilical Hernioplasty (NCT07062497) | Universidade Federal do Rio de Janeiro | 2025-01-07 |
| Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity (NCT06771115) | Zomagen Biosciences Ltd. | 2025-01-07 |
| Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease (NCT05986318) | David Palma | 2025-01-07 |
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (NCT06712316) | BioNTech SE | 2025-01-07 |
| Phase II Study of THDBH120 Injection in Overweight or Obese Subjects (NCT07036601) | Tonghua Dongbao Pharmaceutical Co.,Ltd | 2025-01-06 |
| A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders (NCT06745518) | Taisho Pharmaceutical Co., Ltd. | 2025-01-06 |
| Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients (NCT07079514) | Ziauddin University | 2025-01-06 |
| A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) (NCT06660654) | Daiichi Sankyo | 2025-01-06 |
| SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer (NCT06864013) | First Affiliated Hospital of Zhejiang University | 2025-01-06 |
| A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (NCT06722157) | Boehringer Ingelheim | 2025-01-06 |
| Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose (NCT06316830) | Rhode Island Hospital | 2025-01-06 |
| A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer (NCT05726292) | University of Chicago | 2025-01-06 |
| Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. (NCT06758830) | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | 2025-01-06 |
| SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE） (NCT06767007) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-01-06 |
| Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System (NCT06807359) | SpectraCure AB | 2025-01-06 |
| A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older (NCT06744205) | Sanofi Pasteur, a Sanofi Company | 2025-01-06 |
| Use of CBD in the Treatment of Anxiety (NCT06672666) | University of Florida | 2025-01-06 |
| Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis (NCT06375005) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-01-06 |
| A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma (NCT07257575) | Guangdong Provincial People's Hospital | 2025-01-05 |
| Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment (NCT07285941) | Zhejiang Cancer Hospital | 2025-01-04 |
| Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases (NCT07341919) | Rubens Camargo Siqueira | 2025-01-04 |
| GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. (NCT06851247) | Sun Yat-sen University | 2025-01-03 |
| Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol (NCT06764238) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-03 |
| HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma (NCT06737913) | Sun Yat-sen University | 2025-01-03 |
| A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia (NCT07017725) | CASI pharmaceuticals, Inc. | 2025-01-03 |